BPTH - Bio-Path Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue13--
Cost of Revenue---
Gross Profit13--
Operating Expenses
Research Development5,4743,0201,827
Selling General and Administrative3,0142,4652,715
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-8,475-5,485-4,542
Income from Continuing Operations
Total Other Income/Expenses Net1,7251823
Earnings Before Interest and Taxes-6,750-5,467-4,519
Interest Expense---
Income Before Tax-6,750-5,467-4,519
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-6,750-5,467-4,519
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-6,750-5,467-4,519
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,750-5,467-4,519